Clinical Trial Update: A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Tl-118 in combination with Gemcitabine for metastatic pancreatic cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Tl-118

Snippet

Sponsor: Tiltan Pharma Ltd. | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: UNKNOWN